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The anterior thalamic nuclei are important for spatial and episodic memory, however, surprisingly little
is known about the status of these nuclei in neurological conditions that present with memory im-
pairments, such as Down syndrome. We quantiﬁed neurons and glial cells in the anterior thalamic nuclei
of four older patients with Down syndrome. There was a striking reduction in the volume of the anterior
thalamic nuclei and this appeared to reﬂect the loss of approximately 70% of neurons. The number of glial
cells was also reduced but to a lesser degree than neurons. The anterior thalamic nuclei appear to be
particularly sensitive to effects of aging in Down syndrome and the pathology in this region likely
contributes to the memory impairments observed. These ﬁndings reafﬁrm the importance of examining
the status of the anterior thalamic nuclei in conditions where memory impairments have been princi-
pally assigned to pathology in the medial temporal lobe.
 2018 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Down syndrome (DS; trisomy 21) is the most common chro-
mosomal disorder, affecting 1 in 1000 live births in the UK (Wu and
Morris, 2013). A common feature of DS is learning disabilities with
accompanying language and memory impairments. Over recent
years, there has been a noticeable increase in life expectancy for
adults with DS, with the median life expectancy in England and
Wales currently at 58 years (Wu and Morris, 2013). This increase in
lifespan has resulted in a concomitant increase in the number of
adults with DS affected by dementia, particularly Alzheimer’s dis-
ease (AD), which is considerably more prevalent in adults with DS
than the general population (e.g., Zigman and Lott, 2007). Given the
increased longevity of patients with DS, it has become increasingly
important to understand the underlying changes that occur with
age and dementia in this condition.
Research into mnemonic impairments in DS has typically
focused on medial temporal lobe structures, which are smaller in
patients with DS even when overall brain size is taken into accountardiff University, Cardiff, UK,
Inc. This is an open access article u(Carducci et al., 2013; Kemper, 1991; Krasuski et al., 2002; Pinter
et al., 2001). However, there is an increasing realization that it is
necessary to look beyond the hippocampal formation in conditions
that present with memory impairments. In doing so, the anterior
thalamic nuclei (ATN) become an obvious target because of their
connections with the hippocampal formation and their impor-
tance for memory (Dillingham et al., 2015; Harding et al., 2000;
Jankowski et al., 2013; Van der Werf et al., 2003; Wolff and
Vann, 2018). The presence of neuroﬁbrillary tangles and plaques
in the ATN of patients with AD further highlights the potential
relevance of this structure to DS (Aggleton et al., 2016; Braak and
Braak, 1991a; Rub et al., 2016). Despite these potential links, there
is very little currently known about the status of the ATN in pa-
tients with DS. Neuroimaging studies have only focused on the
thalamus as a whole (e.g., Annus et al., 2017; Teipel et al., 2004),
which does not take into account the structural and functional
heterogeneity in the thalamus. Owing to their size and location, it
is difﬁcult to obtain accurate measures of ATN volume using cur-
rent neuroimaging techniques, which makes postmortem assess-
ments all the more important. Moreover, postmortem tissue
enables examination at the cellular level in addition to volumetric
measures. Therefore, stereological counts of neurons and glial cells
were made in the ATN of four aged female brains with DS and six
age-matched controls.nder the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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2.1. Patient characteristics
Brains from four female patients with DS (mean age 69 years;
range 61e80 years) were provided by the Netherlands Brain Bank
and six female age-matched controls (mean age 71 years; range
60e85 years) were obtained after death according to Danish law
regarding the use of autopsied human tissue in research. The
diagnosis of DS was based on the characteristic physical appearance
of patients and presence of intellectual disability as postmortem
chromosomal analysis was not available (see Table 1 for clinical
data).
Patient 1 (P1) was ﬁrst noted as having seizures at the age of 36
years with an EEG showingmild diffuse cerebral disorder with focal
abnormalities in both temporal regions; the patient was treated
with antiepileptic medication.When shewas 53 years old, patient 1
had been free from seizures for many years but started showing the
ﬁrst symptoms of dementia. Two years after the onset of dementia
symptoms, she was admitted to a nursing home where she grad-
ually deteriorated both mentally and physically. A year before
death, she suffered from several epileptic seizures. The postmortem
report detailed numerous senile plaques and neuroﬁbrillary tangles
within the frontal, temporal, parietal, and occipital lobes and the
hippocampus. The substantia nigra showed very little, if any, cell
loss and the pons, medulla oblongata, and cerebellum all appeared
normal.
Patient 2 (P2) functioned at a moderate level for most of her life,
working in a social working facility for almost 30 years until the age
of 50 years. At the age of 57 years, she was admitted to a home
because of increasing problems in taking care of herself, often
getting lost, suffering from mood swings, and having difﬁculty
taking care of personal needs. At the age of 60 years, it was thought
she had between stage 3 and stage 4 AD and she started to have
minor epileptic insults. EEG showed a diffuse abnormality. Ac-
cording to the postmortem neuropathology report, the brain was
severely atrophied with numerous plaques and tangles across all
lobes and in the hippocampus. The pons, putamen, medulla
oblongata, and cerebellum showed no abnormality.
Patient 3 (P3) was diagnosedwith epilepsy at the age of 26 years.
An EEG carried out when the patient was 37 years showed diffuse
irregular activity. She was admitted into a home when she was 44.
At the age of 60, the patient had a marked decrease in general
functioning with the likely diagnosis of AD, and at 64 years, she was
thought to have stage 2 AD. A report from the following year stated
that shewas unable to differentiate betweenmembers of her family
and nursing home staff and she was disoriented in time and place
with difﬁculties in communication. In the last 2 months beforeTable 1
Participant clinical details
Group Sex ID# Age (y) Height (cm) Hemisphe
Controls F C1 75 159 575
F C2 85 159 590
F C3 64 154 620
F C4 60 161 520
F C5 70 169 667
F C6 74 160 590
Mean 71.3 160.3 594
DS F P1 61 - 444
F P2 64 148 371
F P3 70 162 387
F P4 80 - 537
Mean 68.8 155 435
Key: AMI, acute myocardial infarction; DK, Denmark; DS, Down syndrome; NED, the Nedeath, a cognitive assessment showed her linguistic and commu-
nicative skills to be severely disturbed as were her memory func-
tion, orientation, and concentration. The postmortem
neuropathological report identiﬁed numerous tangles and plaques
in the cortex, hippocampus, and amygdala. The cingulate gyrus
showed severe spongiosis, whereas the medulla oblongata, cervical
medulla, and cerebellum showed no abnormalities.
Patient 4 (P4) was admitted to a nursing home at the age of 66
years with a diagnosis of dementia. However, the patient remained
alert until her death and continued to recognize people and make
demands. An EEG carried out when the patient was 70 years old
showed decreased alpha rhythm and an epileptic predisposition
although clinically there was no indication of epilepsy. The neuro-
pathology report detailed numerous plaques and tangles across the
cortex and hippocampus. The substantia nigra, cingulate gyrus,
locus coeruleus, pons, and cerebellum showed no abnormalities.
The amygdala showed only a few neuroﬁbrillary tangles and senile
plaques.
2.2. Tissue processing
Brains were ﬁxed with 0.1 M sodium phosphateebuffered 4%
formaldehyde (pH 7.2) for a mean of 8 years for DS brains (range
7e9 years) and 15 years for control brains (range 3e22 years). The
cerebrum was detached at the level of the third cranial nerve, the
meninges were removed, and hemispheres were processed as
previously described (Karlsen and Pakkenberg, 2011). Coronal
sections 40-mm thick were stained with Giemsa’s azur eosin
methylene blue solution (Merck, Darmstadt, Germany) and KHPO4
(pH 4.5) in a 1:4 ratio. Slides were coded by a researcher not
involved in data collection to allow blinded analyses. Although
there were variations in ﬁxation time, there was no obvious dif-
ference in tissue quality or counting conditions. Furthermore,
length of time in ﬁxative did not correlate with any measure
(lowest pc ¼ 0.13).
2.3. Cell number and volume estimation
Owing to the difﬁculty in distinguishing between the ante-
romedial and anteroventral thalamic nuclei in Nissl-stained human
tissue, these nuclei were grouped together as the anterior principal
nuclei (APn; Fig. 1AeE) and delineated as previously described
(Armstrong,1990; Harding et al., 2000; Hirai et al., 1989). The APn is
predominantly encapsulated by ﬁbers making it easily identiﬁable;
only the inferior edge of the structure does not have a clear
boundary. The APn was distinguishable from the anterodorsal,
parataenial, and paraventricular thalamic nuclei by laminae that
encapsulate these nuclei. There was a maximum of one section perre (g) Country Cause of death PMI (h) Braak score
DK AMI 24:00
DK AMI 24:00
DK AMI 24:00
DK AMI 48:00
DK AMI 24:00
DK AMI 24:00
NED Pneumonia 05:30 VI
NED Pneumonia 04:00 V
NED Ileus 09:00 VI
NED AMI/pneumonia 06:00 V
therlands; PMI, postmortem interval.
Fig. 1. Photomicrographs of the anterior principal thalamic nucleus (APn). Sections were stained with Giemsa’s azur eosin methylene blue solution. Image montages of the APn
were taken from similar levels from (A) control braindC3 and (BeE) each of the DS brains. The APn is encapsulated by the internal medullary lamina. Examples of the estimated cell
populations (F): N, large (“projection”) neurons; n, small (“inhibitory”) neurons; A, astrocytes; O, oligodendrocytes. Scale bars AeE ¼ 750 mm; Scale bar F ¼ 30 mm. Abbreviation: DS,
Down syndrome. (For interpretation of the references to color in this ﬁgure legend, the reader is referred to the Web version of this article.)
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from the ventral medial tip of the APn. For these sections, where
possible, the lamina separating the paraventricular and central
medial thalamic nuclei from the APn was used as a guide for dis-
tinguishing the ventral medial portion.
The total number of neurons and glial cells were estimated from
one hemisphere per brain using the optical fractionator method
(Gundersen, 1986; West et al., 1991). Slides were mounted on an
Olympus BX60 microscope equipped with a computer-driven XeY
motorized stage (ProScan III Prior, UK) with Z-axis focus control
(Heidenhain Encoder, Germany) and a CMOS camera (Basler,
Germany) connected to a computer running the NewCast Stereol-
ogy software package (Visiopharm, Hørsholm, Denmark). Differ-
entiation of neuron and glial cell types was based on cellmorphology as previously described (Karlsen and Pakkenberg,
2011; Pelvig et al., 2008). In brief, neurons have a single large
nucleolus and a large nucleus surrounded by a visible cytoplasm.
Neurons can be further classiﬁed into “small” local inhibitory
neurons and “large” projecting excitatory neurons based on size
(Armstrong, 1990; Dorph-Petersen et al., 2004). As shown in Fig. 1F,
large and small neurons are easily distinguishable with small
neurons being of comparable size to large astroglia. On the basis of
somal size, thalamic neurons show a bimodal frequency distribu-
tion with very little overlap between the smallest of the large
neurons and the largest of the small neurons (Dewulf, 1971; Dorph-
Petersen et al., 2004). These two types of neurons are only referred
to as small and large in this study as all cell volumes were biased at
least to some degree because of parafﬁn as embedding media and
J.C. Perry et al. / Neurobiology of Aging 75 (2019) 54e61 57should be evaluated in that light. Oligodendrocytes were identiﬁed
as having a small rounded nucleus with dense chromatin and a
perinuclear halo (Fig. 1F). Astrocytes have a pale nucleus sur-
rounded by a translucent cytoplasm and heterochromatin
concentrated in granules in a rim below the nuclear membrane.
Microglia appear small and elongated or comma-shaped with
dense peripheral chromatin. The nucleus was the counting item for
both neurons and glial cells during sampling.
Sampling of sections followed a systematic, uniform random
sampling scheme to ensure all parts of the APn had an equal chance
of being sampled. A section sampling fraction of 1/16 was used
resulting in 9e15 sections sampled per brain (mounted section
thickness 40 mm). The contour of the APn was traced live using a
10 objective (0.4 NA) and cells were counted using a 100 oil
immersion objective (NA 1.35) with a ﬁnal onscreen magniﬁcation
of 3000. A disector height of 20 mm with a 5 mm guard zone was
used to sample in the z-axis. The counting frame areawas 2800 mm2
for neurons and 1350 mm2 for glial cells. The xey step length was
adjusted to allow optimal sampling of brains considered “large” and
“small” but did not change within cases. The xey step length was
set to 400e1000 mm2 for neurons and 800e1000 mm2 for glial cells.
These sampling parameters led to a mean of 206 neurons (range,
152e276) and 631 glial cells (range, 399e1081) counted per brain
in a mean of 222 counting frames (range, 131e466) for neurons and
103 counting frames (range, 45e142) for glial cells. The numbers of
neurons and glial cells were estimated from
N ¼ 1
ssf
:
1
asf
:
1
hsf
:
X
Q;
where ssf is the section sampling fraction; the area sampling frac-
tion (asf) is the ratio of the counting frame area to the area of the
xey step length; the height sampling fraction (hsf) is the ratio of the
disector probe height to the Q weighted tissue thickness; and
P
Q is the total count of cells sampled (Dorph-Petersen et al., 2004).
The density of neurons and glia was calculated as N/volume.
The unilateral volume of the APn was estimated according to
Cavaleri’s principle (Gundersen et al., 1999; Gundersen and Jensen,
1987) but was not corrected for tissue shrinkage as the degree of
shrinkage between control and DS brains was estimated to be the
same in a previous study using the same samples (Karlsen and
Pakkenberg, 2011).
The coefﬁcient of error (CE) was calculated as (Gundersen et al.,
1999) to provide information regarding the precision of the
estimates. The CE for group estimates of each measure was esti-
mated asFig. 2. Amyloid-ß (Aß) staining in the anterior principal thalamic nucleus. Example of Aß sta
control braineC6. Scale bars ¼ 300 mm. Abbreviation: DS, Down syndrome. (For interpreta
version of this article.)CEx ¼
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
CE21 þ CE22 þ.þ CE2n
q
n
where CEx is the mean CE estimate and n is the number of in-
dividuals. As a measure of the variability of the estimates, the
observed interindividual coefﬁcient of variation (CV ¼ standard
deviation/mean) are reported in parentheses after group means.
To provide an indication of the amyloid plaque burden within
the APn, 1e2 midsections from DS brains were available for am-
yloid-ß (Aß) immunohistochemical staining (M0872, 1:1000,
DAKO, Denmark). Applying an adapted point-counting method
(Madsen et al., 2018), we estimated the area fraction percentage of
Aß by overlaying a grid with 100 points spaced equally 115 mm
apart (Fig. 2) with a ﬁnal on-screen magniﬁcation of 220. The
number of grid points hitting the Aß plaques and tissue were
counted to provide the area fraction of the amyloid plaque burden
to tissue.
2.4. Statistics
Differences between groups were tested using an independent
means t-test (two-tailed). Welch’s t-test for unequal variances was
usedwherever appropriate. AMann-Whitney U test was usedwhen
normality tests failed. Wherever relevant, effect sizes between
groups were expressed as Hedges g when equal variances were
assumed, Glass’s D when equal variances were not assumed, or h2
following a Mann-Whitney U test (Fritz et al., 2012). The common
language effect size (CL), the percentage of occasions that a
randomly sampled case from distributionwith the highermeanwill
have a higher score compared with a randomly sampled case from
the distribution with the lower mean (Lakens, 2013; McGraw and
Wong, 1992), is also reported for the key measures total neurons,
total glial cells, and volume to conceptualize the size of these ef-
fects. Pearson’s correlation was used to assess relationships be-
tween variables. The SPSS software (version 20, IBM Corporation)
was used to carry out statistical analyses. The Holm-Bonferroni
procedure was used to correct for multiple comparisons. The cor-
rected p-values (pc) of less than 0.05 were considered signiﬁcant.
The CE estimates for the total number of neurons was 0.07 for
both control and DS brains; for large neurons, it was 0.09 for both
groups; and for small neurons, it was 0.14 for control and 0.11 for DS
brains. The CE estimates for total glial cells was 0.04 for both control
and DS brains; for oligodendrocytes, it was 0.07 for control and 0.08
for DS brains; for astroglia, it was 0.05 for both groups; and forining with a grid-overlay (red crosses) for point counting from (A) DS braineP2 and (B)
tion of the references to color in this ﬁgure legend, the reader is referred to the Web
Fig. 3. Unilateral estimates for anterior principal thalamic nucleus (APn) in control and Down syndrome (DS) brains. Top panel, (A) total neurons (combined large and small
neurons; control ¼ 1.75  106 [0.19], DS ¼ 0.55  106 [0.39]), (B) large (“projecting”) neurons (control ¼ 1.25  106 [0.23], DS ¼ 0.36  106 [0.58]), and (C) small (“local inhibitory”)
neurons (control ¼ 0.50  106 [0.19], DS ¼ 0.20  106 [0.24]). Middle panel, (D) total glial cells (combined astroglia, oligodendrocytes, and microglia; control ¼ 16.84  106 [0.16],
DS ¼ 10.68  106 [0.28]), (E) astroglia (control ¼ 10.60  106 [0.17], DS ¼ 6.92  106 [0.18]), and (F) oligodendrocytes (control ¼ 6.08  106 [0.19], DS ¼ 3.67  106 [0.45]). Bottom
panel, (G) volume of APn (control ¼ 338 mm3 [0.12], DS ¼ 130 mm3 [0.20]), (H) neuron density (control ¼ 5171  mm3 [0.18], DS ¼ 4221  mm3 [0.31]), and (I) glial cell density
(control ¼ 51,509  mm3 [0.14], DS ¼79,649  mm3 [0.18]). The central line in each box indicates the median value. The box extends from the ﬁrst to the third quartile range. The
whiskers extend 1.5 the interquartile range. Individual data points are shifted along the x-axis to aid visualization of overlapping data points. Note that in F, the whisker for the DS
plot extends slightly below zero (not shown). Note that the values in this legend are mean estimates with the coefﬁcient of variation reported in parentheses. Figure symbols refer to
DS brain ID# as follows: diamond P1, square with cross P2, triangle P3, and square P4.*Signiﬁcantly different from control, pc < 0.05; **signiﬁcantly different from control, pc < 0.01;
***signiﬁcantly different from control, pc < 0.001.
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the ﬁnal CE for volume was 0.05 in both control and DS brains.
3. Results
As shown in Fig. 3, therewas a 68% reduction in total numbers of
neurons in the APn of the DS brains compared with controls. This
difference was found to be signiﬁcant (t(7.98) ¼ 6.99, pc < 0.001;
D¼ 3.68, 95% CI 1.67e5.81, CL¼ 99%; Fig. 3A). This overall reduction
reﬂected changes in both large (t(8) ¼ 5.26, pc < 0.01; g ¼ 3.06, 95%
CI 1.22e4.91; Fig. 3B) and small neurons (Mann-Whitney U ¼ 0.00,
pc ¼ 0.029; h2 ¼ 0.65; Fig. 2C).
There was a signiﬁcant 37% reduction in estimated total number
of glial cells in DS brains compared with controls (t(8) ¼ 3.43, pc ¼
0.036; g ¼ 2.00, 95% CI 1.48e5.43, CL ¼ 93%; Fig. 3D). A signiﬁcant
reduction in DS brains was also observed when glial cells were
classiﬁed as astroglia (t(8) ¼ 3.58, pc ¼ 0.036; g ¼ 2.09, 95% CI
0.53e3.65; Fig. 3E). The difference for oligodendrocytes was
borderline signiﬁcant when corrected (t(8) ¼ 2.73 Pc ¼ 0.052, p ¼
0.026; g ¼ 1.59, 95% CI 0.14e3.03; Fig. 3F).
The estimated volume of the APnwas 62% less in DS brains than
controls and this reduction was signiﬁcant (t(7.99) ¼ 10.09, pc <
0.001; D¼ 5.27, 95% CI 2.70e8.05, CL¼ 99%; Fig. 3G). The estimated
density of total neurons for DS brains did not differ from the esti-
mate for controls (t(8) ¼ 1.33, p ¼ 0.22; Fig. 3H). However, the
estimated total glial cell density in DS brains was signiﬁcantly
higher than the estimate in controls, (t(8)¼ 4.12, pc¼ 0.02; g¼ 2.40,
95% CI 0.76e4.05; Fig. 3I). For microglia, the number available for
sampling was consistently low (2e20 per brain), resulting in high
group CE values (0.49e0.51). Controls were estimated to have
1.64  106 (CV, 0.93) microglia, whereas DS brains had 0.94  106
(CV, 0.51) microglia, although this reduction was not signiﬁcant (p
> 0.40).
The area fraction of the APn occupied by Aß in DS brains had a
mean estimate of 7.5% (range, 6%e9%; CV, 0.17). Although no sig-
niﬁcant correlations between Aß and each measure were found,
there was a trend of fewer total neurons (r¼0.62, Pc> 0.40) and a
greater number of total glial cells (r ¼ 0.84, Pc > 0.40) with
increased Aß burden in the APn.
4. Discussion
We estimated the total number of neurons and glial cells in the
combined anteroventral and anteromedial thalamic nuclei (ante-
rior principal thalamic nuclei, APn) of aged women with DS. When
compared with age-matched controls, there were striking changes
with almost 70% fewer neurons in the DS brains, with reductions in
both large and small neurons. Glial cells were also reduced but to a
lesser degree (37%), with comparable changes across astrocytes and
oligodendrocytes. The overall volume of APn was also markedly
reduced (62%) in patients with DS. As a result, there was no dif-
ference in neuronal density between patients with DS and controls.
A similar pattern is found in Korsakoff patients whereby neuron
density is unaffected but overall numbers are reduced by w50%
(Harding et al., 2000), highlighting the importance of assessing
overall cell counts and not just neuronal density.
While the present study focused on the APn, previous studies
using the same brains have reported changes in the mediodorsal
thalamic nucleus and cortical regions (Karlsen et al., 2014; Karlsen
and Pakkenberg, 2011). While the volume of the mediodorsal
thalamic nucleus was reduced to a similar extent as the APn (59%),
the overall cell loss was less with a 43% reduction in neurons but no
changes in glial cells (Karlsen et al., 2014). This highlights the lim-
itations of treating the thalamus as a unitary structure. Further-
more, it becomes clear that simple volumetric measures can masksubstantial variations in patterns of cell loss. Compared with the
cortex, there were greater reductions in the APn when considering
both volume and neuronal count reduction (i.e., w40% for both in
cortex; Karlsen and Pakkenberg, 2011). By contrast, the reduction in
neocortical glial cells was more comparable with the current ﬁnd-
ings (i.e., w30%; Karlsen and Pakkenberg, 2011). Together, the
changes found in APn are more pronounced than other areas
assessed in the same brains, particularly when considering the
reduction in neurons.
While there are some differences between the patient and
control groups in terms of the cause of death, postmortem interval,
and length of time in ﬁxative (see Table 1), the present ﬁndings are
unlikely to be because of these factors (Blair et al., 2016). The basal
ganglia were also examined in these same brains and there was no
neuronal loss in this structure (Karlsen and Pakkenberg, 2011),
conﬁrming the speciﬁcity of the current ﬁndings.
An obvious consideration is the extent to which these APn
changes simply reﬂect the accompanying dementia in this patient
group rather than being directly related to DS, especially given the
ﬁnding that neuronal numbers within some thalamic nuclei have
been shown to correlate with amyloid levels (Erskine et al., 2016,
2017). Pathology related to AD is a common feature in patients
with DS with the onset of amyloid pathology commencing as early
as the late teens and dementia often occurring by the mid 50s
(Davidson et al., 2018; Head et al., 2012). Across the cortex and
hippocampal formation, the development patterns of neuroﬁbril-
lary tangles are comparable across DS and AD groups although
there appears to be more widespread and denser deposition of
amyloid plaques in DS (Hof et al., 1995). However, Braak found no
noticeable difference in AD-related pathology in the anterior thal-
amus of patients with AD with or without DS (Braak and Braak,
1991a). There are surprisingly few studies that have quantitatively
assessed the ATN in AD (without accompanying DS) and even fewer
that have carried out neuronal counts. Although tangles and pla-
ques are present in the APn, it is the anterodorsal thalamic nucleus
that is most severely affected (Braak and Braak, 1991a; Rub et al.,
2016; Xuereb et al., 1991). Consistent with this, Xuereb et al.
(1991) found no signiﬁcant reduction in either volume or
neuronal counts in the APn of patients with AD, although there was
a signiﬁcant reduction in neuronal counts in the anterodorsal nu-
cleus. Similarly, Hornberger et al. (2012) found no signiﬁcant
reduction in ATN volume in patients with AD using either neuro-
imaging or postmortem tissue. Given the small cohort, it is difﬁcult
to draw conclusions regarding AD pathology in the present study.
Two of the patients were categorized as Braak stage 5 and two as
Braak stage 6, which relates to the extent of neuroﬁbrillary pa-
thology in the brain. These are both considered late stages of AD
with abnormal tau pathology extending into the nonlimbic cortical
areas (Braak et al., 2006). There is no clear relationship between
Braak stage of neuroﬁbrillary tangles and APn volume or neuronal
density from the current data. By contrast, the number of glia cells
in the stage 6 patients seems higher than those in stage 5 patients,
especially when considering oligodendrocytes. All patients
appeared to have themost severe Braak staging of amyloid (i.e., “c”),
where amyloid deposits are found across cortical areas (Braak and
Braak, 1991b). Accordingly, our semiquantitative analysis of amy-
loid protein found high levels in the APn in the current patients
with a (nonsigniﬁcant) trend of fewer neurons and a greater
number of glial cells with a greater amyloid presence. Taken
together, the APn pathology we report here does not seem tomirror
what is found in standard AD, but the earlier onset of AD-like pa-
thology in DS and the greater presence of amyloid plaques may
exacerbate the cell loss. Surprisingly, the current ﬁndings show
greater similarity to other dementias such as the semantic variant
of primary progressive aphasia and frontotemporal dementia
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The current ﬁndings raise the question as to whether ATN pa-
thology is a common feature of DS and whether the ATN are also
compromised in younger patients with DS. At present, very little is
known about the status of the ATN in this patient group. Studies in
younger patients have typically only measured the thalamus as a
whole and in doing so have not found any difference between pa-
tient and control groups (Annus et al., 2017; but see; Gunbey et al.,
2017; Jernigan et al., 1993; Weis et al., 1991). However, this
approach may be masking more selective changes within the ATN.
Reports of enlarged 3rd ventricles in younger patients with DS
could also be indicative of atrophy within the ATN (Raz et al., 1995;
Schimmel et al., 2006). Consistent with this, themammillary bodies
were shown to be markedly smaller in adults with DS; moreover,
their size signiﬁcantly correlated with general aptitude (Raz et al.,
1995). Given the reductions in mammillary body and hippocam-
pal volume, and the dense connectivity between these structures
and the ATN (Bubb et al., 2017), it is possible that the ATN are also
compromised at an earlier time point in patients with DS. Pathology
within the extended hippocampal-diencephalic network would be
consistent with the pattern of memory impairments observed in
DS, where there is greater disruption to explicit compared with
implicit memory (Vicari et al., 2000). A similar memory proﬁle is
found after damage to the mammillary body-thalamic axis
(Carlesimo et al., 2007; Tsivilis et al., 2008; Vann et al., 2009).
A limitation of the study is the small sample size, as is often the
case with postmortem studies. However, the pattern of cell loss in
all DS brains was very consistent, both in the APn as well as pre-
vious structures measured (Karlsen et al., 2014; Karlsen and
Pakkenberg, 2011). Furthermore, although we had a low sample
size, the differences found on key measures was reliable, with large
effect sizes. The sample size was, therefore, sufﬁcient to detect the
differences reported, although there are clear limitations in the
correlative inferences that can be made. Small sample sizes can also
produce erroneous effects because of incomplete sampling of the
population; again the consistency in ﬁndings across various mea-
sures makes this less likely to be the case in the current study. There
was also limited information available regarding premortem
cognitive status although from the information available the least
cognitively impaired patient (P4) had the greatest number of APn
neurons.
Together, these data showa striking decrease in both the volume
and cell number of APn in aged patients with DS. The pathology in
this region is likely to contribute to memory impairments given the
importance of this region for mnemonic processes. These ﬁndings
reinforce the need to look beyond the medial temporal lobe when
considering neurological conditions that present with memory
impairments. There is also a clear need to further assess this
structure in future studies of DS to determine the age of onset of
ATN pathology in this patient group.Disclosure
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